Business
Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026
Revenue increased by 11% to $1.4 billion; up 8% on a constant currency basis GAAP gross margin up 290 bps to 62.2%; non-GAAP gross margin up 290 bps to 62.8%GAAP income from operations increased 17%; non-GAAP income from operations up 18%GAAP diluted earnings per share of $2.74; non-GAAP diluted earnings per share of $2.86Operating cash flow of $554 million; $262 million returned to shareholders through share repurchases and dividends Note: A webcast of Resmed’s conference call will be available
About this update from Resmed Inc.
[{"type":"image","alt":"Resmed, Inc.","displaySize":"","headline":null,"caption":"Resmed, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":63,"url":"https://media.zenfs.com/en/globenewswire.com/730e54661ce751c82be107ad83b26aa1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/5YVXbfS.5NH53XQ.naRljQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTg4/https://media.zenfs.com/en/globenewswire.com/730e54661ce751c82be107ad83b26aa1","width":300,"height":63}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue increased by 11% to $1.4 billion; up 8% on a constant currency basis","length":76,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP gross margin up 290 bps to 62.2%; non-GAAP gross margin up 290 bps to 62.8%","length":90,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP income from operations increased 17%; non-GAAP income from operations up 18%","length":91,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP diluted earnings per share of $2.74; non-GAAP diluted earnings per share of $2.86","length":96,"tagName":"p"}]},{"val":[{"type":"text","content":"Operating cash flow of $554 million; $262 million returned to shareholders through share repurchases and dividends","length":114,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":467,"olType":false},{"type":"text","content":"Note: A webcast of Resmed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com","length":118,"tagName":"p"},{"type":"text","content":"SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Resmed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended March 31, 2026.","length":141,"tagName":"p"},{"type":"text","content":"“Our third quarter results reflect the continued strength of our global business, driven by ongoing demand for our market-leading products and disciplined execution of our strategy,” said Resmed’s Chairman and CEO, Mick Farrell.","length":228,"tagName":"p"},{"type":"text","content":""Year-over-year, we delivered 11% reported revenue growth, 290 basis points of non-GAAP gross margin expansion, and 21% increase in earnings per share. These results highlight the momentum behind our strategy, and the continued progress we are making in shaping the future of sleep health, breathing health, and healthcare in ...